Akebia Therapeutics AKBA
$ 1.78
-2.2%
Quarterly report 2024-Q3
added 11-07-2024
Country |
USA |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. John Butler |
Employees in the company |
358 |
Shares |
187 M |
Market Cap[1] |
$ 334 M |
EBITDA (LTM) |
$ -7.26 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.